Latest Form 144 filings
Officers, directors and other affiliates of a company file Form 144 when they place an order to sell restricted or control shares, if they plan to sell more than 5,000 shares or more than $50,000 worth within three months. It is a notice of a planned sale; officers and directors report the sale itself later on Form 4. 13D, 13G and Form 144 explained
Form 144 notices
Newest first. When a Form 144/A amends a notice, only the amendment is listed.
Filed in the last 365 days (US Eastern dates).
Form 144 filings on Livermore: Jan 4, 2023 to Oct 1, 2026.
Notices with a clearly misreported market value are left out of this list and its totals; they still appear, flagged, on the company's page. A value counts as misreported when the price per share it implies is far above the company's prices in Form 4 trades and 13F filings around the planned sale date.
- Notices
- 80
- Market value to sell
- $105.2M
- Sellers
- 11
- Companies
- 1
- Under 10b5-1 plans
- 65
| Company | Filed (ET) | Seller | Shares to sell | Market value | Planned sale | Broker | Filing |
|---|---|---|---|---|---|---|---|
| TVTXTravere Therapeutics, Inc. | Sep 17, 20264:35 PM ET | Eric DubeDirector · Officer | 108.5K | $6.89M | Sep 17, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| TVTXTravere Therapeutics, Inc. | Sep 17, 20264:30 PM ET | Peter HeermaOfficer | 8.28K | $525.7K | Sep 17, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| TVTXTravere Therapeutics, Inc. | Sep 16, 20264:33 PM ET | William RoteOfficer | 112.8K | $7.05M | Sep 16, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| TVTXTravere Therapeutics, Inc. | Sep 16, 20264:32 PM ET | Peter HeermaOfficer | 172.7K | $10.8M | Sep 16, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| TVTXTravere Therapeutics, Inc. | Sep 16, 20264:30 PM ET | Eric DubeDirector · Officer | 195.8K | $12.2M | Sep 16, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| TVTXTravere Therapeutics, Inc. | Sep 15, 20264:44 PM ET | Sandra CalvinOfficer | 5.38K | $353.6K | Sep 15, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| TVTXTravere Therapeutics, Inc. | Sep 15, 20264:44 PM ET | Christopher ClineOfficer | 50.5K | $3.32M | Sep 15, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| TVTXTravere Therapeutics, Inc. | Sep 15, 20264:43 PM ET | Elizabeth ReedOfficer | 39.6K | $2.60M | Sep 15, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| TVTXTravere Therapeutics, Inc. | Sep 15, 20264:42 PM ET | Eric DubeDirector · Officer | 95.7K | $6.29M | Sep 15, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| TVTXTravere Therapeutics, Inc. | Sep 15, 20264:41 PM ET | Peter HeermaOfficer | 102.2K | $6.72M | Sep 15, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| TVTXTravere Therapeutics, Inc. | Sep 15, 20264:35 PM ET | William RoteOfficer | 96.2K | $6.33M | Sep 15, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| TVTXTravere Therapeutics, Inc. | Sep 15, 20264:24 PM ET | Jula InrigOfficer | 44.7K | $2.94M | Sep 15, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| TVTXTravere Therapeutics, Inc. | Sep 10, 20264:38 PM ET | Jeffrey MecklerDirector | 20.0K | $1.32M | Sep 10, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| TVTXTravere Therapeutics, Inc. | Aug 18, 20264:24 PM ET | Gary LyonsDirector | 5.00K | $317.6K | Aug 18, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| TVTXTravere Therapeutics, Inc. | Aug 17, 20264:31 PM ET | Gary A LyonsDirector | 5.00K | $310.7K | Aug 17, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| TVTXTravere Therapeutics, Inc. | Jun 12, 20264:05 PM ET | Roy BaynesDirector | 4.50K | $225.0K | Jun 12, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| TVTXTravere Therapeutics, Inc. | Jun 12, 202612:20 PM ET | Coughlin TimothyDirector | 10.0K | $500.4K | Jun 12, 202610b5-1 | Wells Fargo Clearing Services | SEC |
| TVTXTravere Therapeutics, Inc. | May 15, 202612:51 PM ET | Coughlin TimothyDirector | 3.25K | $141.2K | May 15, 202610b5-1 | Wells Fargo Clearing Services | SEC |
| TVTXTravere Therapeutics, Inc. | May 6, 20264:03 PM ET | Christopher ClineOfficer | 310 | $13.6K | May 6, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| TVTXTravere Therapeutics, Inc. | May 6, 20264:03 PM ET | Elizabeth ReedOfficer | 2.08K | $91.2K | May 6, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| TVTXTravere Therapeutics, Inc. | May 6, 20264:02 PM ET | Jula InrigOfficer | 311 | $13.7K | May 6, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| TVTXTravere Therapeutics, Inc. | May 6, 20269:55 AM ET | Dube Eric MOfficer | 22.5K | $988.9K | May 6, 202610b5-1 | Fidelity Brokerage Services LLC | SEC |
| TVTXTravere Therapeutics, Inc. | May 6, 20269:37 AM ET | Rote William E.Officer | 2.76K | $121.4K | May 6, 202610b5-1 | Fidelity Brokerage Services LLC | SEC |
| TVTXTravere Therapeutics, Inc. | May 5, 20267:48 PM ET | Christopher ClineOfficer | 2.18K | $101.7K | May 5, 2026 | Morgan Stanley Smith Barney | SEC |
| TVTXTravere Therapeutics, Inc. | May 5, 20267:32 PM ET | Elizabeth E. ReedOfficer | 2.17K | $101.4K | May 5, 2026 | Morgan Stanley Smith Barney | SEC |
| TVTXTravere Therapeutics, Inc. | May 5, 20267:31 PM ET | Jula InrigOfficer | 2.17K | $101.4K | May 5, 2026 | Morgan Stanley Smith Barney | SEC |
| TVTXTravere Therapeutics, Inc. | May 5, 20267:31 PM ET | Peter HeermaOfficer | 2.17K | $101.4K | May 5, 2026 | Morgan Stanley Smith Barney | SEC |
| TVTXTravere Therapeutics, Inc. | May 5, 20264:53 PM ET | Roy BaynesDirector | 4.50K | $209.9K | May 5, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| TVTXTravere Therapeutics, Inc. | May 4, 20264:04 PM ET | Elizabeth ReedOfficer | 20.0K | $900.0K | May 4, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| TVTXTravere Therapeutics, Inc. | May 4, 20264:04 PM ET | Jeffrey MecklerDirector | 8.00K | $360.0K | May 4, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| TVTXTravere Therapeutics, Inc. | May 4, 20264:03 PM ET | Jula InrigOfficer | 20.0K | $900.0K | May 4, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| TVTXTravere Therapeutics, Inc. | May 1, 20264:15 PM ET | Roy BaynesDirector | 9.75K | $431.1K | May 1, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| TVTXTravere Therapeutics, Inc. | Apr 22, 202610:36 AM ET | Rote William E.Officer | 9.10K | $355.7K | Apr 22, 202610b5-1 | Fidelity Brokerage Services LLC | SEC |
| TVTXTravere Therapeutics, Inc. | Apr 15, 20264:16 PM ET | Dube Eric MOfficer | 64.0K | $2.63M | Apr 15, 202610b5-1 | Fidelity Brokerage Services LLC | SEC |
| TVTXTravere Therapeutics, Inc. | Apr 15, 20264:15 PM ET | Elizabeth ReedOfficer | 6.79K | $283.8K | Apr 15, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| TVTXTravere Therapeutics, Inc. | Apr 15, 20264:14 PM ET | Christopher ClineOfficer | 1.01K | $43.2K | Apr 15, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| TVTXTravere Therapeutics, Inc. | Apr 15, 20264:13 PM ET | Jula InrigOfficer | 1.02K | $43.4K | Apr 15, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| TVTXTravere Therapeutics, Inc. | Apr 14, 20269:17 PM ET | Elizabeth E. ReedOfficer | 7.21K | $302.5K | Apr 14, 2026 | Morgan Stanley Smith Barney | SEC |
| TVTXTravere Therapeutics, Inc. | Apr 14, 20268:53 PM ET | Jula InrigOfficer | 7.21K | $302.5K | Apr 14, 2026 | Morgan Stanley Smith Barney | SEC |
| TVTXTravere Therapeutics, Inc. | Apr 14, 20268:47 PM ET | Peter HeermaOfficer | 7.21K | $302.5K | Apr 14, 2026 | Morgan Stanley Smith Barney | SEC |
| TVTXTravere Therapeutics, Inc. | Apr 14, 20268:40 PM ET | Christopher ClineOfficer | 7.24K | $303.5K | Apr 14, 2026 | Morgan Stanley Smith Barney | SEC |
| TVTXTravere Therapeutics, Inc. | Apr 14, 20264:27 PM ET | Gary A LyonsOfficer | 8.00K | $245.6K | Apr 14, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| TVTXTravere Therapeutics, Inc. | Apr 14, 20264:20 PM ET | Christopher ClineOfficer | 9 | $369.63 | Apr 14, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| TVTXTravere Therapeutics, Inc. | Apr 14, 20264:19 PM ET | Elizabeth ReedOfficer | 37.5K | $1.54M | Apr 14, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| TVTXTravere Therapeutics, Inc. | Apr 14, 20264:09 PM ET | Roy BaynesDirector | 32.8K | $1.35M | Apr 14, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| TVTXTravere Therapeutics, Inc. | Apr 14, 20264:02 PM ET | Sandra CalvinOfficer | 22.0K | $902.6K | Apr 14, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| TVTXTravere Therapeutics, Inc. | Apr 13, 20268:11 PM ET | Christopher ClineOfficer | 65 | $1.88K | Apr 13, 2026 | Morgan Stanley Smith Barney | SEC |
| TVTXTravere Therapeutics, Inc. | Apr 6, 20264:06 PM ET | Roy BaynesDirector | 10.0K | $330.0K | Apr 6, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| TVTXTravere Therapeutics, Inc. | Apr 1, 20264:13 PM ET | Dube Eric MOfficer · Director | 60.0K | $1.86M | Apr 1, 202610b5-1 | Fidelity Brokerage Services LLC | SEC |
| TVTXTravere Therapeutics, Inc. | Apr 1, 20264:06 PM ET | Elizabeth ReedOfficer | 10.0K | $300.0K | Apr 1, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |